An Extension Protocol to Evaluate Dose Comparisons of Leucine-Metformin Combinations in Type 2 Diabetic Patients
NCT02435277
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
Low Metformin
DRUG:
Mid Metformin
DRUG:
High Metformin
DRUG:
Metformin
Sponsor
NuSirt Biopharma